Zymeworks Inc.

Zymeworks Inc. is a privately held computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics. Zymeworks is entering into strategic collaborations to optimize existing therapeutics, and is committed to building a pipeline of antibody-based therapeutics through improving failed or abandoned assets. Furthermore, Zymeworks is exploring the improvement of marketed protein therapeutics and to create second generation versions with improved efficacies. Our cross functional teams use Zymeworks’ integrated modeling, simulation and analysis platforms ZymeCAD™ and ResidueNetworks™ in combination with biochemical and biophysical data to design and optimize therapeutic antibodies.